CIMR Neuromuscular Research Biobank
Virginia Commonwealth University · NCT05434572
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 500
- US sites recruiting
- 1
- Study start
- March 17, 2021
- Record last updated
- July 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research repository is to collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate. These samples will be stored at Virginia Commonwealth University (VCU) and will be used for future research with this population.
Conditions: Neuromuscular Diseases; Neuromuscular Disorder; Neuromuscular Diseases in Children
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Willing and able to give informed consent
- Positive diagnosis or suspected diagnosis of neuromuscular disease, or
- Family history of neuromuscular disease, or
- Healthy volunteer
- Age Neonates-75
Exclusion Criteria
- Unwilling to sign consent
Recruiting US locations
Virginia Commonwealth University
Richmond, VA 23298
Site contact: Carino Jennings · 804-828-1271 · carino.garza@vcuhealth.org
Study contacts (from the official record)
- Nicholas Johnson · 804-628-1624 · nicholas.johnson@vcuhealth.org
Similar studies in Virginia
All healthy volunteers studies in Virginia →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Charlottesville, VA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Charlottesville, VA + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Richmond, VA + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
HTIC, Inc
- Location
- Richmond, VA
- Eligibility basics
- Ages 18–65